
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA? (before April 2027)
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs.


